Literature DB >> 20706045

F-18 FDG PET/CT findings in pulmonary necrotizing sarcoid granulomatosis.

Julia Arfi1, Khaldoun Kerrou, Samba Traore, Virginie Huchet, Antoine Bolly, Martine Antoine, Luc Delaunois, Thierry Vander Borght, Jean-Noël Talbot.   

Abstract

Necrotizing sarcoid granulomatosis (NSG) is a rare systemic disease that was described by Liebow in 1973. Dyspnea and chest pain may be present, as in our first patient; however, 25% of patients are asymptomatic, as our second patient. The typical radiographic findings are nonspecific: single or multiple lung opacities, with common involvement of the pleura. To the best of our knowledge, fluorodeoxyglucose (FDG) PET has only been reported in one case of NSG, which was atypical as it occurred in an adolescent. We report 2 cases, confirming that the lesions of NSG are FDG positive, showing a typical pattern of multiple bilateral lung nodules (imaged with PET/CT in 1 case). FDG imaging has a potential role when this distribution is observed on CT, to guide the surgical biopsy and show the actual extent of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20706045     DOI: 10.1097/RLU.0b013e3181e9fade

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Necrotizing Sarcoid Granulomatosis with Natural Resolution after a Surgical Lung Biopsy.

Authors:  Takayuki Shibata; Koichiro Takahashi; Masaru Uchida; Fumio Yamasaki; Michihiro Kawashima; Naoko Sueoka-Aragane
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

2.  Necrotizing Sarcoid Granulomatosis Mimicking Lung Malignancy: MDCT, PET-CT and Pathologic Findings.

Authors:  Hilal Sahin; Naim Ceylan; Selen Bayraktaroglu; Sezai Tasbakan; Ali Veral; Recep Savas
Journal:  Iran J Radiol       Date:  2012-03-25       Impact factor: 0.212

Review 3.  Necrotizing sarcoid granulomatosis with hemoptysis: a case report and literature review.

Authors:  Haidong Huang; Chen Li; Chong Bai; Qiang Li; Weiqiang Zheng; Zhi Zhu; Paul Zarogoulidis; Konstantinos Zarogoulidis; Andreas Gschwendtner; Wolfgang Hohenforst-Schmidt; Michael Simoff
Journal:  Diagn Pathol       Date:  2013-05-13       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.